Global malaria treatment market is growing tremendously across the globe due to the rise in medical insurance and additionally pandemic outbreak of coronavirus disease (COVID-19) across globe. The various categories of the medication malaria treatment include chloroquine, mefloquine, quinine, primaquine, hydroxychloroquine, artemisinin-based combination therapy (ACT), non-artemisinin based combinations (non-acts) and others. The increased research and development activities lead to the increased product launch by key market players of the global malaria treatment market. However adverse effects and risks associated with anti-malaria may hamper the future growth of malaria treatment market.